Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,207 | -20,648 | -4,459 | -1,913 | N/A |
| Depreciation Amortization | 257 | 20 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 225 | 793 | 64 | 71 | N/A |
| Other Working Capital | -1,728 | 938 | -206 | 293 | N/A |
| Other Operating Activity | 2,045 | 1,023 | 18 | -62 | 0 |
| Operating Cash Flow | $-27,408 | $-17,874 | $-4,583 | $-1,611 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 117,715 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,906 | -774 | N/A | N/A | N/A |
| Purchase Of Investment | -89,854 | -79,120 | 0 | N/A | N/A |
| Investing Cash Flow | $25,955 | $-79,894 | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 423 | 86,257 | 0 | N/A | N/A |
| Other Financing Activity | 0 | 13,119 | 12,719 | 483 | 0 |
| Financing Cash Flow | $423 | $99,376 | $12,719 | $483 | $N/A |
| Beginning Cash Position | 10,271 | 8,663 | 527 | 1,655 | N/A |
| End Cash Position | 9,241 | 10,271 | 8,663 | 527 | N/A |
| Net Cash Flow | $-1,030 | $1,608 | $8,136 | $-1,128 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,408 | -17,874 | -4,583 | -1,611 | N/A |
| Capital Expenditure | -1,906 | -774 | N/A | N/A | N/A |
| Free Cash Flow | -29,314 | -18,648 | -4,583 | -1,611 | 0 |